GILEAD SCIENCES, INC. (GILD)
Biological Products, (No Diagnostic Substances) · Biological Products, (No Diagnostic Substances) · NASDAQ
$149.61
-0.21%
Investru Score
64.3 / 100
Good
Why is GILD moving?
GILD is little changed today (-0.21%).
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
GILD’s Investru Score changed +0 points recently. Want to know exactly what changed and why? That’s a Pro feature →
Score breakdown
- Financial Quality
- 79
- Growth
- 44
- Profitability
- 63
- Balance Sheet
- 48
- Valuation
- 64
- Momentum
- 93
Score history
+0.0 over the last 3 days, driven mainly by valuation (-1).
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- 19.0%
- ROE
- 37.5%
- FCF Margin
- 32.1%
- Free Cash Flow (TTM)
- $9.5B
- Earnings Quality (OCF ÷ Net Income)
- 1.2x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- Data unavailable
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- Data unavailable
- Company Median PEG
- Data unavailable
- Price / Sales
- 6.3x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 5.1%
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q2 FY26 EPS
- $-8.45
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q2 FY26 · period ended 2026-06-30Filed 2026-08-06
- 10-Q · Q1 FY26 · period ended 2026-03-31Filed 2026-05-07
- 10-K · FY25 · period ended 2025-12-31Filed 2026-02-24
- 10-Q · Q3 FY25 · period ended 2025-09-30Filed 2025-11-07
- 10-Q · Q2 FY25 · period ended 2025-06-30Filed 2025-08-07
- 10-K · FY24 · period ended 2024-12-31Filed 2025-02-28
- 10-K · FY23 · period ended 2023-12-31Filed 2024-02-23
- 10-K · FY22 · period ended 2022-12-31Filed 2023-02-22
- 10-K · FY21 · period ended 2021-12-31Filed 2022-02-23
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $185.7B · 52-week range $108.46–$157.29 · market data as of Sep 2, 2026, 4:00 PM ET · latest SEC filing: 2021-02-25
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze GILD with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.